Search tips
Search criteria 


Logo of ijmbJournal's HomeManuscript SubmissionAims and ScopeAuthor GuidelinesEditorial BoardHome
Int J Microbiol. 2009; 2009: 653481.
Published online 2009 February 11. doi:  10.1155/2009/653481
PMCID: PMC2774579

Growth and Survival of Acid-Resistant and Non-Acid-Resistant Shiga-Toxin-Producing Escherichia coli Strains during the Manufacture and Ripening of Camembert Cheese


Growth and survival of acid-resistant (AR) and non-acid-resistant (NAR) Shiga-toxin-producing Escherichia coli (STEC) strains were investigated during the manufacture and ripening of microfiltered milk Camembert cheeses. The induction of acid resistance of the STEC strains in cheeses was also studied. Six different mixtures of AR and/or NAR STEC strains were inoculated separately into microfiltered milk at a level of 103 CFU mL−1. The STEC counts (AR and NAR) initially increased by 1 to 2 log10 CFU g−1 during cheese-making. Thereafter, the populations stabilized during salting/drying and then decreased during the early stages of ripening. Exposing the STEC strains in artificially inoculated cheeses to simulated gastric fluid (SGF - pH: 2.0) reduced the number of NAR strains to undetectable levels within 40 minutes, versus 120 minutes for the AR STEC strains. AR and NAR STEC were able to survive during the manufacture and ripening of Camembert cheese prepared from microfiltered milk with no evidence of induced acid tolerance in NAR STEC strains.

1. Introduction

Shiga-toxin- (Stx-) producing Escherichia coli strains, including E. coli O157:H7, are a worldwide cause of human disease with a wide spectrum of symptoms ranging from mild diarrhea to life-threatening hemolytic-uremic syndrome (HUS). The Stx-producing family of human disease-associated E. coli is also characterized by its diversity of toxin type (i.e., lysogenic either for the Stx1-encoding phage or the Stx2-encoding phage, or with both lysogens) and by its O:H serotype range [1, 2].

In spite of diverse virulence characteristics, one common trait that emerges very clearly is that most of these strains have the ability to withstand gastric acidity [36] or the conditions in acidic foods [79]. It is noteworthy that acid tolerance plays a vital role in the survival and virulence of diarrheagenic E. coli strains [1012]. The ability of E. coli O157:H7 strains to survive in acidic conditions has been studied extensively [1316], but there are few reports about the tolerance of non-O157 STEC serogroups to organic acids in foods [17, 18]. It is thought that acid resistance and/or induction of acid tolerance may enable pathogens to survive gastrointestinal acidity better and so, ultimately, cause disease [1922]. Cattle are considered to be a major reservoir of E. coli O157:H7 for human infection [23]. The pathogen has been isolated from raw milk [24], and multiple outbreaks of E. coli O157:H7 linked to the ingestion of raw milk and dairy products have been reported [25, 26]. Several authors have studied the ability of E. coli O157:H7 to grow and survive in different types of cheese. In fresh cheese, E. coli O157:H7 increased by 2 log (CFU per gram) during cheese manufacture [27], but total inactivation was obtained during heat treatment (57°C for more than 1.5 hours) of the curd and whey. Reitsma and Henning (1996) found that this microorganism was able to grow during Cheddar cheese manufacture, even with an initial inoculum in milk of only 1 CFU mL−1. E. coli O157:H7 also survived the manufacture and storage of Camembert and Feta cheeses at 2 ± 1°C for 65 and 75 days, respectively [28].

Moreover, this pathogen was able to survive all stages of smear-ripened cheese production for up to 70 days postmanufacture [29].

E. coli O157:H7 was not eliminated from goat's milk lactic cheese, made with raw milk, because this organism tolerates the low pH [30] and low temperatures [31, 32] which characterize the manufacturing and ripening process.

Surprisingly, studies on contamination of milk, or its products, with non-O157 E. coli have been limited. Two studies from France have reported STEC prevalence in cheeses [33, 34], 3 studies reported results for ewes' and caprine milk cheeses [3537] and, very recently, a study described the prevalence of STEC in Swiss raw milk cheeses [38]. Moreover, there are no published experiments evaluating the growth or survival of non-O157 STEC in cheeses.

However, non-O157 E. coli infections are, within European member states, considered to be at least as important as E. coli O157:H7 infections though they are thought to be generally underdiagnosed [39]. For example, in Italy [40], Denmark [41], and Germany [42], more than 40% of the confirmed cases of STEC-related HUS were caused by non-O157 STEC. More recently, in 2005, French raw milk Camembert-type cheeses contaminated by Escherichia coli O26 and O80 caused 16 HUS cases and a national and international recall of the entire production of cheeses [43]. Other human infections with non-O157 STEC from dairy products are well documented [4447]. These outbreaks suggest that the acid tolerance of the non-O157 STEC strains, like the O157 STEC strains, enables these bacteria to survive in moderately acidic food. Acid tolerance is defined by the growth of log-phase cultures at a moderately low pH (pH 5.5 to 6.0) inducing mechanisms of survival in the more extreme acid conditions of pH 2.5 [48]. A similar phenomenon, termed the “acid tolerance response,” has been demonstrated in S. typhimurium [49, 50].

The purpose of the present work was to address the question of whether the acidic resistance confers an ecological superiority. This potential ecological superiority of STEC strains was evaluated by the ability of acid-resistant (AR) and non-acid-resistant (NAR) STEC strains to survive the fermentation process of Camembert-type cheeses.

In a previous study, we have investigated the fate of E. coli O157:H7 during the manufacture and ripening of raw goat's milk lactic cheeses and noted that E. coli O157:H7 was able to survive the cheese-making process [51].

The main objectives of the present study were firstly to evaluate the growth and survival of AR and NAR Shiga-toxin-producing E. coli strains and, secondly, to check whether microfiltered milk Camembert cheeses could induce acid tolerance in inoculated NAR STEC strains.

2. Materials and Methods

2.1. Bacterial Strains and Culture Conditions

A collection of 62 STEC strains were isolated during previous French epidemiological studies, whose purpose was to determine STEC contamination prevalence in dairy products, in pork, and in the environment [34, 5254].

With the aim of evaluating the ability of these bacteria to survive exposure to acid, we used the protocol described by Castanie-Cornet et al. [10], in which three AR mechanisms were tested. These mechanisms are as follows:

  1. AR1: oxidative system (glucose–repressed system),
  2. AR2: system depending on the presence of glutamate,
  3. AR3: system depending on the presence of arginine.

A fourth mechanism is a fermentative acid resistance system. It was tested according to the method previously described by Large et al. [55].

Four AR STEC and four NAR STEC strains were selected from a previous study (data not shown). The survival rate of the strains in the presence of glucose and amino acids is displayed in Table 1. Two spontaneous nalidixic acid-resistant mutants were selected in vitro for each AR and NAR STEC strain, previously selected by plating STEC on BHI agar containing nalidixic acid (0.1 to 10 μg/mL) in increasing concentrations, using the protocol described by Truong et al. [56]. Three rifampicin and three spectinomycin mutants were selected using the same protocol. The antibiotic susceptibility of these AR or NAR mutants is shown in Table 1. To follow the growth of these strains during the manufacture and ripening of the Camembert cheese, spontaneous antibiotic-resistant derivatives (nalidixic acid, rifampicin, and spectinomycin) were isolated. We carefully checked that the chosen resistant derivatives were neither affected in their growth rate nor in their acid-resistance properties (data not shown).

Table 1
Virulence factors and acid resistance of the STEC strains used for the artificial contamination of milk.

2.2. Microfiltered Cow Milk

Raw cow milk samples were collected aseptically from the bulk storage tank after it had been cooled to <5°C and maintained refrigerated at 3°C for transportation to Actilait. Cheeses were made with raw cow milk standardized [57] by microfiltration. Raw milk was microfiltered at 40°C through a 1.4 μm ceramic Membralox membrane (Pall Exekia, Bazet, France).

The microfiltered cow milk was analyzed, in order to check that it was not contaminated by STEC, by performing a Polymerase Chain Reaction (PCR) for Shiga-toxin coding genes (stx genes) after an enrichment step, as described by Fremaux et al. [58].

2.3. Inoculation Procedure and Preparation of the STEC Mixtures

Cultures of antibiotic-resistant STEC strains were maintained at −80°C in cryopreservative beads (STARLAB, Bagneux, France). Prior to preparing the inoculation mixtures, each culture of antibiotic-resistant STEC strains was incubated overnight (18 hours) in LB broth at 37°C. Strains were grown individually at 37°C for 24 hours in LB broth, with or without antibiotics, to reaffirm that the strains retained resistance. All overnight cultures were centrifuged at 8000 × g for 10 minutes. Cells were washed twice in 0.1% peptone water and suspended in 0.1% peptone water to achieve the required inoculation (106 CFU mL−1) level by standardization of the absorbance at A600 nm using a spectrophotometer (BioPhotometer, Eppendorf, Le Pecq, France). Mixtures were prepared by combining the 3 adequate STEC strains in equal amounts. They were designed corresponding with the need to have 3 different antibiotic-resistant or non-resistant phenotypes in the same mixture. The 6 mixtures of STEC strains used for this experimentation are detailed in Table 2.

Table 2
Composition of the STEC strains mixtures used for the inoculation of milk.

The STEC population in each mixture was confirmed by plating 100 μL of the suspension onto LB-A plates supplemented with the appropriate antibiotic to verify the initial inoculum levels. Six millilitres of mixture were inoculated into 6.5 L of milk to obtain a final concentration in the microfiltered milk of approximately 103 CFU mL−1 of STEC.

Twelve batches of cheeses were prepared (two batches per mixture) and 4 batches of uninoculated cheese samples served as negative controls (1 batch per manufacturing day).

2.4. Cheese Manufacture

Artisanal microfiltered cow's milk lactic cheeses were prepared following the industrial specifications of the French Institute of cheese (Actilait).

The milk was inoculated (2 × 1011 CFU per 100 kg) with mesophilic starters MM100 (Lactococcus lactis subsp. lactis, cremoris, and lactis biovar diacetylactis), (Rhodia, Dangé-Saint-Romain, France) as well as ripening flora Penicillium camemberti (Pc P9, 4 doses per 1000 kg Cargill, St Germain en Laye, France), Geotrichum candidum (GCA, 2 doses per 1000 kg, Cargill) and 10.5 mL of a solution of CaCl2 was also added per 100 kg of milk. The inoculated milk was matured for 2 hours at 32°C and renneting was carried out using 30 mL of rennet per 100 L of milk (at 530 mgL−1 of chymosin, Berthelot, ABIA S.A. Meursault, France). The milk coagulated after 8 minutes and was left undisturbed until the pH decreased to 6.15. The curd was cut into 3 cm cubes, healed for 30 minutes (pH minimum = 6.00), drained and transferred to 77 × 110 mm cylindrical plastic moulds. Cheeses drained for 20–22 hours at 20°C were turned twice during this time. Cheeses weighing approximately 250 g were removed from the mould, and the temperature of the cheese-making chamber was reduced to 20–22°C. After 20 hours, the cheeses were plunged into a saturated brine solution at 10°C for 25 minutes. Cheeses were dried at 13°C for 5 hours and matured at 11°C and 95% relative humidity for 20 days, then finally packaged and stored at 4°C.

The manufacturing protocol for lactic cheeses made with microfiltered is outlined in Figure 1.

Figure 1
Flowchart for the manufacture of lactic cheeses made with microfiltered milk.

2.5. Sampling Steps

Physicochemical and bacteriological analyses were performed at the following steps.

  • Step 1: Microfiltered milk before the maturation stage.
  • Step 2: Curd during draining (3 hours 20 minutes).
  • Step 3: Cheese at the end of the moulding stage (3 hours 45 minutes).
  • Step 4: Cheese after salting (1 day).
  • Step 5: Cheese after drying (1 day).
  • Step 6: Cheese at the middle of the ripening stage (10 days).
  • Step 7: Cheese at the end of ripening (20 days).

2.6. Microbiological Analysis

During cheese manufacture, 25 mL samples of microfiltered milk or 25 g of drained curd or cheese (rind and core) were sampled and homogenized with 225 mL of Buffered Peptone Water (BPW, bioMérieux, Marcy l'Etoile, France) in a sterile bag filter (BagSystem 400 mL Model+, Interscience, Saint Nom la Breteche, France) and stomached for 30 seconds (Stomacher Mix1, AES Laboratory, Bruz, France). The filtered liquid was diluted in BPW and spread, using spiral plating (WASP Spiral plating, AES Laboratory, Bruz, France), onto LB-A plates. LB-A plates were supplemented with rifampicin (100 μg mL−1), spectinomycin (100 μg mL−1), or nalidixic acid (40 μg mL−1), when appropriate, and incubated for 24 hours at 37°C. Enumeration of the colonies was performed with an automatic colony counter EC2 easy count 2 (AES Laboratory, Bruz, France).

2.7. Physical-Chemical Measurements

The pH was measured for each cheese (inoculated or not inoculated) at each time of sampling. For the chemical measurements, analyses were performed on the raw milk after microfiltration and on the noninoculated (negative controls) cheeses after 1 day (before brining) and 20 days (end of the ripening stage). Milk fat content was determined by the acido-butyrometric method of Gerber, according to AFNOR (NF V 04-210), and the milk protein rate was obtained using the amido black method (AFNOR, NF V 04-216). Cheese moisture content was determined with an infrared-dryer (Précisa XM60), according to AFNOR (NF V 04-282), and the cheese fat content was measured by the Heiss butyrometric method [59]. The ripened cheese salt content was determined using a chloride analyzer (AFNOR, NF V 04-288).

Cheese pHs were measured using a penetration electrode (pH meter 330, Fisher Bioblock Scientific, F67403 Illkirch Cedex, France).

2.8. Exposure of STEC, Present in Artificially Inoculated Cheeses, to Simulated Gastric Fluid (SGF)

Simulated gastric fluid was prepared accorded to the protocol used by Yuk and Marshall [60]. More precisely, simulated gastric fluid consisted of 8.3 g L−1 of proteose-peptone (Fluka-Biochemika, Switzerland), 3.5 g L−1 of D-glucose (Fluka-Biochemika, Switzerland), 2.05 g L−1 of NaCl (Sigma-Aldrich, Lyon, France), 0.6 g L−1 of KH2PO4 (Merck Sharp & Dohme, Paris, France), 0.11 g L−1 of CaCl2 (Sigma-Aldrich, Lyon, France), 0.37 g L−1 of KCl (Sigma-Aldrich, Lyon, France), 0.05 g L−1 of ox bile (Sigma-Aldrich, Lyon, France), 0.1 g L−1 of lysozyme (Sigma-Aldrich, Lyon, France), and 13.3 mg L−1 of pepsin (Sigma-Aldrich, Lyon, France). The final pH was adjusted to 1.5 using sterile 5.0 N HCl (Merck Sharp & Dohme, Paris, France). All compounds were autoclaved separately, except for the ox bile, lysozyme, and pepsin which were filter sterilized, followed by aseptic mixing.

However, 90 mL of SGF (pH 1.5), at 37°C, were added aseptically to 10 g of inoculated cheese sampled at the end of the ripening stage. To obtain a final inoculated SGF at pH 2.5, the pH of each sample was lowered to 2.5 using (5.0 N) HCl.

For the enumeration of each STEC strain (Table 1) belonging to the different mixtures used for the inoculation of the milk, homogenate cheese samples were taken at regular time intervals. Viable cell densities were determined by spiral plating appropriate dilutions in TS onto LB-A plates containing rifampicin (100 μg mL−1), spectinomycin (100 μg mL−1), or nalidixic acid (40 μg mL−1). LB-A plates were incubated at 37°C for 24 hours and enumeration of the colonies was performed with an automatic colony counter EC2 easy count 2 (AES Laboratory, Bruz, France).

3. Results

3.1. PH and Physicochemical Properties During Manufacture and Ripening of the Cheeses

Cheese production was performed in a dairy laboratory in order to provide commercial conditions during production. The chemical composition of the cheese samples produced from the microfiltered milks is shown in Table 3. The fat and protein content in the microfiltered milks were 37.00% and 32.58% w/w, respectively.

Table 3
Physicochemical properties of Camembert cheeses.

The pH of the milk was 6.45 ± 0.02. It declined slightly to 6.03 (SD: ±0.02) during the first 4 hours (draining of curdled milk). Then the pH decreased markedly from 6.03 to 4.65 (SD: ±0.05) at the end of moulding step (24 hours). The pH remained almost stable until the 10th day (4.64 to 4.75) (SD: ±0.02) and increased slightly over the last 10 days of the ripening period to a pH of 5.11 (SD: ±0.03) (Table 4).

Table 4
Changes in pH values during cheese processing.

3.2. Survival of STEC During Lactic Cheese Manufacture

STEC was never isolated from any of the milk samples collected from the bulk storage tank nor from any of the negative control cheeses.

There were no differences between the counts of NAR and AR STEC strains during the manufacture and ripening of the microfiltered milk lactic cheeses.

As an example, Figure 2 shows the survival of 4 STEC mixtures: the AR2 (3 AR STEC strains), AS2 (3 NAR STEC strains), ARSSb2 (2 NAR and 1 AR STEC strains), and ASRRa2 (2 AR and 1 NAR STEC strains) mixtures during cheese manufacture (Table 2).

Figure 2
Counts of STEC strains during the cheese manufacture. AR2: 3 AR STEC strains, AS2: 3 NAR STEC strains, ARSSb2: 1 AR and 2 NAR STEC strains, ASRRa2: 2 AR and 1 NAR STEC strains. AR strains: black lines, symbols: [open triangle], [large circle], ×. NAR strains: ...

In general, whatever the mixture used, STEC counts increased by a range of 1 to 2 2 log CFU g−1 during the first steps of the cheese manufacturing and remained relatively stable after salting until the drying stage of the cheeses. Then, during ripening (20 days), the counts of only one NAR STEC strain (346ASpec) decreased to 10 CFU g−1. The other AR or NAR STEC strains were all counted at levels ranging from 102 to 104 CFU g−1 (Figure 2).

3.3. Survival of STEC in Simulated Gastric Fluid, pH 2

At the end of ripening (20 days), samples of inoculated cheeses were placed in simulated gastric fluid where the numbers of surviving STEC cells were assessed at 5, 10, 20, 30, 40, 50, 60, 90, and 120 minutes.

Exposure to SGF (pH: 2.5) reduced the number of NAR STEC strains to undetectable levels within 40, 50, and 60 minutes for ANR 42ANal, ANR 418ARif-346ASpec, and 360BRif, respectively. In contrast to the NAR STEC strains, all the AR STEC strains survived an exposure of more than 120 minutes in SGF at pH 2.5 (Table 5).

Table 5
Survival rates of STEC strains in simulated gastric fluid at pH: 2.

4. Discussion

Multiple applications of low levels of acid stress during the life cycles of Escherichia coli O157:H7 and other pathogens might increase their likelihood for survival in foods and may enhance the development and establishment of stress-adapted strains with potentially increased virulence in food environments [6163]. Although acid tolerance in E. coli O157:H7 is normally transient, being induced at low pH [14, 30, 64, 65], some outbreak strains (e.g., ATCC 43895) have attained a permanently high, pH-independent acid resistance [17], probably because of an evolutionary response to severe acid stress.

The objective of the present study was to investigate the growth and survival of AR and NAR STEC strains in Camembert-type cheeses. None of our findings have been subjected to a statistical analysis since we have used mixtures of 3 STEC strains for the inoculation of the milk and, hence, some interaction between STEC strains could occur. The use of mixtures, instead of a single strain, is explained by the limited number of batches (16) allowed by Actilait and the decision to study the kinetics of 8 different STEC strains. Moreover, it was not possible to study pathogenic STEC strains, such as E. coli O157:H7 or E. coli O26, due to the lack of safety level/P3 laboratories.

The number of STEC increased from 1 to 2 log10 at the beginning of the cheese manufacture, whilst the pH decreased slightly from 6.45 (milk pH) to 6.03 (first 4 hours). Much of this initial increase could be attributed to the entrapment of STEC in the curd during coagulation followed by further concentration during whey drainage. Then we noted a plateau phase in the growth of STEC from the “cheese at the end of moulding” stage (pH: 4.65) to the “cheese after drying” stage (pH: 4.66). From the middle of ripening (10 days, pH: 4.75) to the end of ripening (20 days, pH 5.11), the STEC population decreased markedly. In much the same way, after 24 hours of manufacture and storage of Camembert cheese inoculated at 104 CFU mL−1, Ramsaran et al. [28] observed an increase in E. coli O157:H7 counts of about 2 log10 . This increase was followed by a decrease in the counts of E. coli O157:H7 in all of the cheeses throughout ripening and storage at 2°C.

Vernozy-Rozand et al. [51] showed that significant numbers of viable E. coli O157:H7 could be detected in raw goat milk lactic cheeses even 42 days after processing. In Cheddar cheeses, aged for 60 and 120 days, and stored at 7°C, the E. coli O157:H7 population was reduced by less than 2 log [66]. Marek et al. [67] reported that E. coli O157:H7 could persist in unpasteurized Cheddar cheese whey inoculated at 105 or 102 CFU mL−1 for up to 2-3 weeks of storage at 4, 10, or 15°C. The results of Maher et al. [29] showed the presence of E. coli O157:H7 even after 90 days in the rind and after 50 days in the core of smear ripened cheese produced from raw milk.

The acid adaptation response is a phenomenon by which microorganisms show an increased resistance to environmental stress after exposure to a moderate acid environment. In this study, the acid adaptation of 4 NAR STEC strains was not induced by the slow and mild acid conditions (4.65–4.75) found during the lactic cheese process because these strains were rapidly destroyed during the strong acid exposure in simulated gastric fluid (pH 2.5).

Hsin-Yi and Chou [68] noted the same effects in fermented milk but a completely opposite effect in acid fruit juice. The authors explained that acid adaptation might lead to an increased susceptibility of the test organism to antimicrobials, such as bacteriocins, hydrogen peroxide, ethanol, and diacetyl, produced by lactic acid bacteria in milk products. The effect of increasing susceptibility to these antimicrobials, due to acid adaptation, may outweigh the effect of enhancing acid tolerance, reducing the survival of acid-adapted E. coli O157:H7 in the milk products. Jordan et al. [30] observed that E. coli O157:H7 is able to induce an adaptive tolerance response (ATR) when exposed to mild acid conditions, thus conferring a higher resistance on subsequent exposure to strong acid conditions. Bergholz and Whittam [69] studied the survival of enterohaemorrhagic Escherichia coli of serotypes O157:H7, O26:H11, and O111:H8 in a simulated gastric environment. Their results indicated that E. coli O157:H7 strains were better able to survive in a simulated gastric environment than the STEC strains belonging to the two other serogroups. The authors indicated that this difference was reduced when cultures were held at stationary phase for longer periods of time, suggesting that E. coli O157:H7 cells rapidly achieve an enhanced state of AR in the early stationary phase, an ability that may underlie the low infectious dose of this pathogen.

The present study indicates that AR and NAR STEC strains, when initially present at 103 CFU mL−1 in milk, would most likely survive artisanal Camembert-type cheese manufacture and ripening (20 days). The biggest decrease was observed for an NAR STEC strain (346ASpec) whose counts reached 10 CFU g−1 at 20 days. Even if we must keep in mind that the inoculation levels were certainly higher than those observed in naturally contaminated milk, the low infectious dose associated with pathogenic STEC suggests that the 20 day ripening period of these cheeses may not guarantee a safe product for consumers if STEC are present in the raw milk. Consequently, good milk hygiene is crucial in order to reduce the risk of the presence of pathogens in the raw milk cheeses. Moreover, acid adaptation of NAR STEC strains during the manufacture of cheeses prior to their exposure to simulated gastric fluid did not increase the acid resistance of the bacteria. On the basis of these results, additional investigations will be undertaken to evaluate the behavior of STEC during the manufacture of cheeses using a rapid curdling phase linked to a greater drop in acidity than that employed in the present cheese technology.


This research was supported by funds from the National Agency of Research (ANR), (ANR-05-PNRA-021).


1. Kaper JB, Nataro JP, Mobley HLT. Pathogenic Escherichia coli. Nature Reviews Microbiology. 2004;2(2):123–140. [PubMed]
2. Meng J, Doyle MP. Escherichia coli O157: H7 and other Shiga toxin-producing E. coli strains. In: Kaper JB, O'Brien AD, editors. Microbiology of Shiga Toxin-Producing Escherichia coli in Foods. Washington, DC, USA: AMS Press; 1998. pp. 92–108.
3. Foster JW, Moreno M. Bacterial Responses to pH. New York, NY, USA: John Wiley & Sons; 1999. Inducible acid tolerance mechanisms in enteric bacteria; pp. 55–69. (Novartis Foundation Symposia no. 221).
4. Lin J, Lee IS, Frey J, Slonczewski JL, Foster JW. Comparative analysis of extreme acid survival in Salmonella typhimurium, Shigella flexneri, and Escherichia coli. Journal of Bacteriology. 1995;177(14):4097–4104. [PMC free article] [PubMed]
5. Merrell DS, Camilli A. Acid tolerance of gastrointestinal pathogens. Current Opinion in Microbiology. 2002;5(1):51–55. [PubMed]
6. Waterman SR, Small PLC. Acid-sensitive enteric pathogens are protected from killing under extremely acidic conditions of pH 2.5 when they are inoculated onto certain solid food sources. Applied and Environmental Microbiology. 1998;64(10):3882–3886. [PMC free article] [PubMed]
7. Morgan D, Newman CP, Hutchinson DN, Walker AM, Rowe B, Majid F. Verotoxin producing Escherichia coli O157 infections associated with the consumption of yoghurt. Epidemiology and Infection. 1993;111(2):181–187. [PMC free article] [PubMed]
8. Uljas HE, Ingham SC. Combinations of intervention treatments resulting in 5-log10-unit reductions in numbers of Escherichia coli O157:H7 and Salmonella typhimurium DT104 organisms in apple cider. Applied and Environmental Microbiology. 1999;65(5):1924–1929. [PMC free article] [PubMed]
9. Zhao T, Doyle MP, Besser RE. Fate of enterohemorrhagic Escherichia coli O157:H7 in apple cider with and without preservatives. Applied and Environmental Microbiology. 1993;59(8):2526–2530. [PMC free article] [PubMed]
10. Castanie-Cornet M-P, Penfound TA, Smith D, Elliott JF, Foster JW. Control of acid resistance in Escherichia coli. Journal of Bacteriology. 1999;181(11):3525–3535. [PMC free article] [PubMed]
11. Price SB, Wright JC, DeGraves FJ, Castanie-Cornet M-P, Foster JW. Acid resistance systems required for survival of Escherichia coli O157:H7 in the bovine gastrointestinal tract and in apple cider are different. Applied and Environmental Microbiology. 2004;70(8):4792–4799. [PMC free article] [PubMed]
12. Slonczewski JL, Foster JW. pH-regulated genes and survival at acidic pH. In: Neidhardt FC, Curtiss R III, Ingraham JL, et al., editors. Escherichia coli and Salmonella: Cellular and Molecular Biology. 2nd edition. Vol. 1. Washington, DC, USA: ASM Press; 1996. pp. 1539–1549.
13. Conner DE, Kotrola JS. Growth and survival of Escherichia coli O157:H7 under acidic conditions. Applied and Environmental Microbiology. 1995;61(1):382–385. [PMC free article] [PubMed]
14. Leyer GJ, Wang L-L, Johnson EA. Acid adaptation of Escherichia coli O157:H7 increases survival in acidic foods. Applied and Environmental Microbiology. 1995;61(10):3752–3755. [PMC free article] [PubMed]
15. Miller LG, Kaspar CW. Escherichia coli O157:H7 acid tolerance and survival in apple cider. Journal of Food Protection. 1994;57(6):460–464.
16. Reinders RD, Biesterveld S, Bijker PGH. Survival of Escherichia coli O157:H7 ATCC 43895 in a model apple juice medium with different concentrations of proline and caffeic acid. Applied and Environmental Microbiology. 2001;67(6):2863–2866. [PMC free article] [PubMed]
17. Benjamin MM, Datta AR. Acid tolerance of enterohemorrhagic Escherichia coli. Applied and Environmental Microbiology. 1995;61(4):1669–1672. [PMC free article] [PubMed]
18. McKellar RC, Knight KP. Growth and survival of various strains of enterohemorrhagic Escherichia coli in hydrochloric and acetic acid. Journal of Food Protection. 1999;62(12):1466–1469. [PubMed]
19. Arnold KW, Kaspar CW. Starvation- and stationary-phase-induced acid tolerance in Escherichia coli O157:H7. Applied and Environmental Microbiology. 1995;61(5):2037–2039. [PMC free article] [PubMed]
20. Diez-Gonzalez F, Callaway TR, Kizoulis MG, Russell JB. Grain feeding and the dissemination of acid-resistant Escherichia coli from cattle. Science. 1998;281(5383):1666–1668. [PubMed]
21. Gorden J, Small PLC. Acid resistance in enteric bacteria. Infection and Immunity. 1993;61(1):364–367. [PMC free article] [PubMed]
22. O'Driscoll B, Gahan CGM, Hill C. Adaptive acid tolerance response in Listeria monocytogenes: isolation of an acid-tolerant mutant which demonstrates increased virulence. Applied and Environmental Microbiology. 1996;62(5):1693–1698. [PMC free article] [PubMed]
23. Doyle MP. Escherichia coli O157:H7 and its significance in foods. International Journal of Food Microbiology. 1991;12(4):289–301. [PubMed]
24. Reitsma CJ, Henning DR. Survival of enterohemorrhagic Escherichia coli O157:H7 during the manufacture and curing of cheddar cheese. Journal of Food Protection. 1996;59(5):460–464.
25. Altekruse SF, Timbo BB, Mowbray JC, Bean NH, Potter ME. Cheese-associated outbreaks of human illness in the United States, 1973 to 1992: sanitary manufacturing practices protect consumers. Journal of Food Protection. 1998;61(10):1405–1407. [PubMed]
26. Honish L, Predy G, Hislop N, et al. An outbreak of E. coli O15:H7 hemorrhagic colitis associated with unpasteurized gouda cheese. Canadian Journal of Public Health. 2005;96(3):182–184. [PubMed]
27. Arocha MM, McVey M, Loder SD, Rupnow JH, Bullerman L. Behavior of hemorrhagic Escherichia coli O157:H7 during the manufacture of cottage cheese. Journal of Food Protection. 1992;55:379–381.
28. Ramsaran H, Chen J, Brunke B, Hill A, Griffiths MW. Survivial of bioluminescent Listeria monocytogenes and Escherichia coli O157:H7 in soft cheeses. Journal of Dairy Science. 1998;81(7):1810–1817. [PubMed]
29. Maher MM, Jordan KN, Upton ME, Coffey A. Growth and survival of E. coli O157:H7 during the manufacture and ripening of a smear-ripened cheese produced from raw milk. Journal of Applied Microbiology. 2001;90(2):201–207. [PubMed]
30. Jordan K, Oxford L, O'Byrne CP. Survival of low pH stress by Escherichia coli O157:H7: correlation between alterations in the cell envelope and increase acid tolerance. Applied and Environmental Microbiology. 1999;65(7):3048–3055. [PMC free article] [PubMed]
31. Massa S, Goffredo E, Altieri C, Natola K. Fate of Escherichia coli O157: H7 in unpasteurized milk stored at 8[composite function (small circle)]C. Letters in Applied Microbiology. 1999;28(1):89–92. [PubMed]
32. Wang G, Zhao T, Doyle MP. Survival and growth of Escherichia coli O157:H7 in unpasteurized and pasteurized milk. Journal of Food Protection. 1997;60(6):610–613.
33. Pradel N, Livrelli V, De Champs C, et al. Prevalence and characterization of Shiga toxin-producing Escherichia coli isolated from cattle, food, and children during a one-year prospective study in France. Journal of Clinical Microbiology. 2000;38(3):1023–1031. [PMC free article] [PubMed]
34. Vernozy-Rozand C, Montet MP, Berardin M, Bavai C, Beutin L. Isolation and characterization of Shiga toxin-producing Escherichia coli strains from raw milk cheeses in France. Letters in Applied Microbiology. 2005;41(3):235–241. [PubMed]
35. Caro I, García-Armesto MR. Occurrence of Shiga toxin-producing Escherichia coli in a Spanish raw ewe's milk cheese. International Journal of Food Microbiology. 2007;116(3):410–413. [PubMed]
36. Mora A, León SL, Blanco M, et al. Phage types, virulence genes and PFGE profiles of Shiga toxin-producing Escherichia coli O157:H7 isolated from raw beef, soft cheese and vegetables in Lima (Peru) International Journal of Food Microbiology. 2007;114(2):204–210. [PubMed]
37. Rey J, Sánchez S, Blanco JE, et al. Prevalence, serotypes and virulence genes of Shiga toxin-producing Escherichia coli isolated from ovine and caprine milk and other dairy products in Spain. International Journal of Food Microbiology. 2006;107(2):212–217. [PubMed]
38. Stephan R, Schumacher S, Corti S, Krause G, Danuser J, Beutin L. Prevalence and characteristics of Shiga toxin-producing Escherichia coli in Swiss raw milk cheeses collected at producer level. Journal of Dairy Science. 2008;91(7):2561–2565. [PubMed]
39. Johnson KE, Thorpe CM, Sears CL. The emerging clinical importance of non-O157 Shiga toxin-producing Escherichia coli. Clinical Infectious Diseases. 2006;43(12):1587–1595. [PubMed]
40. Tozzi AE, Caprioli A, Minelli F, et al. Shiga toxin-producing Escherichia coli infections associated with hemolytic uremic syndrome, Italy, 1988–2000. Emerging Infectious Diseases. 2003;9(1):106–108. [PMC free article] [PubMed]
41. Piérard D, Cornu G, Proesmans W, et al. Hemolytic uremic syndrome in Belgium: incidence and association with verocytotoxin-producing Escherichia coli infection. Clinical Microbiology and Infection. 1999;5(1):16–22. [PubMed]
42. Gerber A, Karch H, Allerberger F, Verweyen HM, Zimmerhackl LB. Clinical course and the role of Shiga toxin-producing Escherichia coli infection in the hemolytic-uremic syndrome in pediatric patients, 1997–2000, in Germany and Austria: a prospective study. The Journal of Infectious Diseases. 2002;186(4):493–500. [PubMed]
43. Espié E, Grimont F, Mariani-Kurkdjian P, et al. Surveillance of hemolytic uremic syndrome in children less than 15 years of age, a system to monitor O157 and non-O157 Shiga toxin-producing Escherichia coli infections in France, 1996–2006. The Pediatric Infectious Disease Journal. 2008;27(7):595–601. [PubMed]
44. Centers for Disease Control and Prevention (CDC) Outbreak of acute gastroenteritis attributable to Escherichia coli serotype O104:H21—Helena, Montana, 1994. Morbidity and Mortality Weekly Report. 1995;44(27):501–503. [PubMed]
45. Deschênes G, Casenave C, Grimont F, et al. Cluster of cases of haemolytic uraemic syndrome due to unpasteurised cheese. Pediatric Nephrology. 1996;10(2):203–205. [PubMed]
46. Gallien P, Richter H, Klie H, et al. Detection of STEC and epidemiological investigations in surrounding of a HUS patient. Berliner und Munchener Tierarztliche Wochenschrift. 1997;110(9):342–346. [PubMed]
47. Wilson JB, Clarke RC, Renwick SA, et al. Vero cytotoxigenic Escherichia coli infection in dairy farm families. Journal of Infectious Diseases. 1996;174(5):1021–1027. [PubMed]
48. Goodson M, Rowbury RJ. Habituation to normally lethal acidity by prior growth of Escherichia coli at a sub-lethal acid pH value. Letters in Applied Microbiology. 1989;8(2):77–79.
49. Foster JW. The acid tolerance response of Salmonella typhimurium involves transient synthesis of key acid shock proteins. Journal of Bacteriology. 1993;175(7):1981–1987. [PMC free article] [PubMed]
50. Foster JW, Hall HK. Adaptive acidification tolerance response of Salmonella typhimurium. Journal of Bacteriology. 1990;172(2):771–778. [PMC free article] [PubMed]
51. Vernozy-Rozand C, Mazuy-Cruchaudet C, Bavai C, et al. Growth and survival of Escherichia coli O157:H7 during the manufacture and ripening of raw goat milk lactic cheeses. International Journal of Food Microbiology. 2005;105(1):83–88. [PubMed]
52. Bouvet J, Montet MP, Rossel R, et al. Prevalence of verotoxin-producing Escherichia coli (VTEC) and E. coli O157:H7 in French pork. Journal of Applied Microbiology. 2002;93(1):7–14. [PubMed]
53. Gourmelon M, Montet MP, Lozach S, et al. First isolation of Shiga toxin 1d producing Escherichia coli variant strains in shellfish from coastal areas in France. Journal of Applied Microbiology. 2006;100(1):85–97. [PubMed]
54. Vernozy-Rozand C, Montet MP, Bertin Y, et al. Serotyping, stx2 subtyping, and characterization of the locus of enterocyte effacement island of Shiga toxin-producing Escherichia coli and E. coli O157:H7 strains isolated from the environment in France. Applied and Environmental Microbiology. 2004;70(4):2556–2559. [PMC free article] [PubMed]
55. Large TM, Walk ST, Whittam TS. Variation in acid resistance among Shiga toxin-producing clones of pathogenic Escherichia coli. Applied and Environmental Microbiology. 2005;71(5):2493–2500. [PMC free article] [PubMed]
56. Truong QC, Van Nguyen J-C, Shlaes D, Gutmann L, Moreau NJ. A novel, double mutation in DNA gyrase A of Escherichia coli conferring resistance to quinolone antibiotics. Antimicrobial Agents and Chemotherapy. 1997;41(1):85–90. [PMC free article] [PubMed]
57. Daufin G, Escudier J-P, Carrère H, Bérot S, Fillaudeau L, Decloux M. Recent and emerging applications of membrane processes in the food and dairy industry. Food and Bioproducts Processing. 2001;79(2):89–102.
58. Fremaux B, Raynaud S, Beutin L, Rozand CV. Dissemination and persistence of Shiga toxin-producing Escherichia coli (STEC) strains on French dairy farms. Veterinary Microbiology. 2006;117(2–4):180–191. [PubMed]
59. Heiss E. Rapid method for the determination of fat in cheese. Deutsche Molkerei-Zeitung. 1966;82:67–70.
60. Yuk H-G, Marshall DL. Adaptation of Escherichia coli O157:H7 to pH alters membrane lipid composition, verotoxin secretion, and resistance to simulated gastric fluid acid. Applied and Environmental Microbiology. 2004;70(6):3500–3505. [PMC free article] [PubMed]
61. Archer DL. Preservation microbiology and safety: evidence that stress enhances virulence and triggers adaptive mutations. Trends in Food Science & Technology. 1996;7(3):91–95.
62. Buncic S, Avery SM. Effects of cold storage and heat-acid shocks on growth and verotoxin 2 production of Escherichia coli O157:H7. Food Microbiology. 1998;15(3):319–328.
63. Samelis J, Sofos JN. Microbial Stress Adaptation and Food Safety. Boca Raton, Fla, USA: CRC Press; 2003. Strategies to control stress-adapted pathogens; pp. 303–351.
64. Buchanan RL, Edelson SG. Culturing enterohemorrhagic Escherichia coli in the presence and absence of glucose as a simple means of evaluating the acid tolerance of stationary-phase cells. Applied and Environmental Microbiology. 1996;62(11):4009–4013. [PMC free article] [PubMed]
65. Lin J, Smith MP, Chapin KC, Baik HS, Bennett GN, Foster JW. Mechanisms of acid resistance in enterohemorrhagic Escherichia coli. Applied and Environmental Microbiology. 1996;62(9):3094–3100. [PMC free article] [PubMed]
66. Schlesser JE, Gerdes R, Ravishankar S, Madsen K, Mowbray J, Teo AY-L. Survival of a five-strain cocktail of Escherichia coli O157:H7 during the 60-day aging period of cheddar cheese made from unpasteurized milk. Journal of Food Protection. 2006;69(5):990–998. [PubMed]
67. Marek P, Nair MKM, Hoagland T, Venkitanarayanan K. Survival and growth characteristics of Escherichia coli O157:H7 in pasteurized and unpasteurized Cheddar cheese whey. International Journal of Food Microbiology. 2004;94(1):1–7. [PubMed]
68. Hsin-Yi C, Chou C-C. Acid adaptation and temperature effect on the survival of E. coli O157:H7 in acidic fruit juice and lactic fermented milk product. International Journal of Food Microbiology. 2001;70(1-2):189–195. [PubMed]
69. Bergholz TM, Whittam TS. Variation in acid resistance among enterohaemorrhagic Escherichia coli in a simulated gastric environment. Journal of Applied Microbiology. 2007;102(2):352–362. [PubMed]

Articles from International Journal of Microbiology are provided here courtesy of Hindawi Publishing Corporation